{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:22:10Z","timestamp":1787008930725,"version":"build-2736575974"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Are the LH levels at the start of ovarian stimulation predictive of suboptimal oocyte yield from GnRH agonist triggering in GnRH antagonist down-regulated cycles?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>LH levels at the start of ovarian stimulation are an independent predictor of suboptimal oocyte yield following a GnRH agonist trigger.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>A GnRH agonist ovulation trigger may result in an inadequate oocyte yield in a small subset of patients. This failure can range from empty follicle syndrome to the retrieval of much fewer oocytes than expected. Suboptimal response to a GnRH agonist trigger has been defined as the presence of circulating LH levels &lt;15\u00a0IU\/l 12\u00a0h after triggering. It has been shown that patients with immeasurable LH levels on trigger day have an up to 25% risk of suboptimal response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>In this retrospective cohort study, all patients (n\u00a0=\u20093334) who received GnRH agonist triggering (using Triptoreline 0.2\u00a0mg) for final oocyte maturation undergoing a GnRH antagonist cycle in our centre from 2011 to 2017 were included. The primary outcome of the study was oocyte yield, defined as the ratio between the total number of collected oocytes and the number of follicles with a mean diameter &gt;10\u00a0mm prior to GnRH agonist trigger.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>The endocrine profile of all patients was studied at initiation as well as at the end of ovarian stimulation. In order to evaluate whether LH levels, not only at the end but also at the start, of ovarian stimulation predicted oocyte yield, we performed multivariable regression analysis adjusting for the following confounding factors: female age, body mass index, oral contraceptives before treatment, basal and trigger day estradiol levels, starting FSH levels, use of highly purified human menopausal gonadotrophin and total gonadotropin dose. Suboptimal response to GnRH agonist trigger was defined as &lt;10th percentile of oocyte yield.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>The average age was 31.9\u00a0years, and the mean oocyte yield was 89%. The suboptimal response to GnRH agonist trigger cut-off (&lt;10th percentile) was 45%, which was exhibited by 340 patients. Following confounder adjustment, multivariable regression analysis showed that LH levels at the initiation of ovarian stimulation remained an independent predictor of suboptimal response even in the multivariable model (adjusted OR 0.920, 95% CI 0.871\u20130.971). Patients with immeasurable LH levels at the start of stimulation (&lt;0.1\u00a0IU\/l) had a 45.2% risk of suboptimal response, while the risk decreased with increasing basal LH levels; baseline circulating LH &lt;0.5\u00a0IU\/L, &lt;2\u00a0IU\/L and &lt;5\u00a0IU\/L were associated with a 39.1%, 25.2% and 13.6% risk, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The main limitation of the study is its retrospective design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>This is the largest study of GnRH agonist trigger cycles only, since most of the previous research on the predictive value of basal LH levels was performed in dual trigger cycles. LH values should be measured prior to start of ovarian stimulation. In cases where they are immeasurable, suboptimal response to GnRH agonist trigger can be anticipated, and an individualized approach is warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>There was no funding and no competing interests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/dez132","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T07:08:45Z","timestamp":1561705725000},"page":"2027-2035","source":"Crossref","is-referenced-by-count":46,"title":["Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation"],"prefix":"10.1093","volume":"34","author":[{"given":"B","family":"Popovic-Todorovic","sequence":"first","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Santos-Ribeiro","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"},{"name":"IVI-RMA, Lisboa, Avenida Infante Dom Henrique, Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Drakopoulos","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"De Vos","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Racca","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mackens","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Thorrez","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Verheyen","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tournaye","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Quintero","sequence":"additional","affiliation":[{"name":"IMER - Instituto de Medicina Reproductiva, Avda. de Burjassot, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Blockeel","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan, Jette, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"2019102315394262000_ref1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10815-013-9966-4","article-title":"Failure of GnRH agonist-triggered oocyte maturation: its cause and management","volume":"30","author":"Asada","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"2019102315394262000_ref44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.rbmo.2012.03.015","article-title":"Estradiol valerate pretreatment in GnRH-antagonist cycles","volume":"25","author":"Blockeel","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2019102315394262000_ref2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/jcem-50-1-179","article-title":"Gonadotropin-estradiol responses to a superactive luteinizing hormone-releasing hormone agonist in women","volume":"50","author":"Casper","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019102315394262000_ref3","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMcp0800459","article-title":"Clinical practice. Precocious puberty","volume":"358","author":"Carel","year":"2008","journal-title":"N Engl J Med"},{"key":"2019102315394262000_ref4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10815-011-9704-8","article-title":"Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS","volume":"29","author":"Castillo","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"2019102315394262000_ref5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.fertnstert.2016.06.013","article-title":"Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response","volume":"106","author":"Chang","year":"2016","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/humrep\/dey215","article-title":"Novel homozygous nonsense mutations in LHCGR lead to empty follicle syndrome and 46, XY disorder of sex development","volume":"33","author":"Chen","year":"2018","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/humrep\/des049","article-title":"Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol","volume":"27","author":"Chen","year":"2012","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)60906-8","article-title":"Disappearance of exogenously administered human chorionic gonadotropin","volume":"52","author":"Damewood","year":"1989","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref9","first-page":"203","article-title":"Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial","volume":"6","author":"Decleer","year":"2014","journal-title":"Facts Views Vis Obgyn Vlaamse Vereniging voor Obstetrie en Gynaecologie"},{"key":"2019102315394262000_ref10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2015.12.007","article-title":"GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis","volume":"32","author":"Engmann","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"2019102315394262000_ref11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019102315394262000_ref43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.fertnstert.2015.02.004","article-title":"Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger","volume":"103","author":"Fatemi","year":"2015","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019102315394262000_ref13","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","article-title":"Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders","volume":"97","author":"Griffin","year":"2012","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejogrb.2011.03.002","article-title":"Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports","volume":"157","author":"Honnma","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019102315394262000_ref15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref16","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","article-title":"Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jama.2014.14488","article-title":"Safety of assisted reproductive technology in the United States, 2000\u20132011","volume":"313","author":"Kawwass","year":"2015","journal-title":"JAMA"},{"key":"2019102315394262000_ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/humrep\/dei348","article-title":"Effect of oral contraceptive pill pre-treatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial","volume":"21","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref19","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/humrep\/deh471","article-title":"Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF","volume":"19","author":"Kolibianakis","year":"2004","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/humrep\/des361","article-title":"Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger","volume":"28","author":"Kummer","year":"2013","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2003.05.032","article-title":"Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome","volume":"81","author":"Kol","year":"2004","journal-title":"Fertil Steril"},{"key":"2019102315394262000_reflaw","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09513590.2016.1266325","article-title":"Individual luteolysis post GnRH-agonist-trigger in GnRH-antagonist protocols","volume":"33","author":"Lawrenz","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2019102315394262000_ref22","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.fertnstert.2016.07.1068","article-title":"Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist","volume":"106","author":"Lu","year":"2016","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","article-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study","volume":"19","author":"Melo","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2019102315394262000_ref24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.fertnstert.2015.06.011","article-title":"Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles","volume":"104","author":"Meyer","year":"2015","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0002-9378(77)90295-2","article-title":"The effect of contraceptive steroids on hypothalamic-pituitary function","volume":"128","author":"Mishell","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"2019102315394262000_ref26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10815-016-0755-8","article-title":"GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone","volume":"33","author":"O'Neill","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2019102315394262000_ref27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1297-9589(00)00064-3","article-title":"Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin","volume":"29","author":"Parneix","year":"2001","journal-title":"Gynecol Obstet Fertil"},{"key":"2019102315394262000_ref28","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/humrep\/del072","article-title":"GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study","volume":"21","author":"Pirard","year":"2006","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref29","first-page":"727569","article-title":"Contribution to more patient-friendly ART treatment: efficacy of continuous low-dose GnRH agonist as the only luteal support-results of a prospective randomized comparative study","author":"Pirard","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2019102315394262000_ref30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0015-0282(16)53231-2","article-title":"Role of the amplitude of the gonadotropin surge in the rat","volume":"53","author":"Peluso","year":"1990","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10815-015-0498-y","article-title":"Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and \"freeze-all\": in-depth analysis of genetic predisposition","volume":"32","author":"Santos-Ribeiro","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2019102315394262000_ref32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10815-018-1372-5","article-title":"Rare genetic variants potentially involved in ovarian hyperstimulation syndrome","volume":"36","author":"Stouffs","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2019102315394262000_ref33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0015-0282(16)46288-6","article-title":"Biological rhythm of the luteinizing hormone surge in women","volume":"37","author":"Seibel","year":"1982","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.fertnstert.2007.06.030","article-title":"Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization","volume":"90","author":"Shapiro","year":"2008","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2010.09.009","article-title":"Efficacy of induced luteinizing hormone surge after \u201ctrigger\u201d with gonadotropin-releasing hormone agonist","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref36","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref37","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(96)05291-9","article-title":"Factors that affect outcome of in-vitro fertilisation treatment","volume":"348","author":"Templeton","year":"1996","journal-title":"Lancet"},{"key":"2019102315394262000_ref38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jcem-33-6-917","article-title":"The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function","volume":"33","author":"Tsai","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2019102315394262000_ref39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fertnstert.2015.10.014","article-title":"Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study","volume":"105","author":"Vuong","year":"2016","journal-title":"Fertil Steril"},{"key":"2019102315394262000_ref40","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/humrep\/dex015","article-title":"Genetic evidence of 'genuine' empty follicle syndrome: a novel effective mutation in the LHCGR gene and review of the literature","volume":"32","author":"Yuan","year":"2017","journal-title":"Hum Reprod"},{"key":"2019102315394262000_ref41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5935\/1518-0557.20170036","article-title":"Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial","volume":"21","author":"Zarcos","year":"2017","journal-title":"JBRA Assist Reprod"},{"key":"2019102315394262000_ref42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/jcem-73-3-577","article-title":"Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function","volume":"73","author":"Zelinski-Wooten","year":"1991","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/34\/10\/2027\/30279258\/dez132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/34\/10\/2027\/30279258\/dez132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T15:40:05Z","timestamp":1571845205000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/34\/10\/2027\/5575090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,9,27]]},"published-print":{"date-parts":[[2019,10,2]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dez132","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,9,27]]}}}